Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ ...

Gilead Sciences and Assembly Biosciences have announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) ...

Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...

Is there a “least bad” alcohol? Is Benadryl harming your health? Here are the answers you wanted most this year.

Using 3-dimensional skin models cultured in the laboratory to discover how cells in the human skin limit infection with the important human pathogen, herpes simplex virus. This studentship comes with ...

– 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of ABI-1179, ...

Good evening, and welcome to the Assembly Bio conference call. [Operator Instructions] Please be advised that today's conference is being recorded and will be available for replay on the Assembly Bio ...

Herpes symptoms usually appear about four days after being exposed to the virus. Even without symptoms, you can spread herpes to someone else. That being said, the timeline can vary from one person to ...

Researchers at the University of Georgia have developed a promising new drug that could change the way we treat chickenpox, shingles, and even herpes. Dr. David Chu and Dr. Uma Singh led the ...

Since the onset of the COVID-19 outbreak, numerous articles have highlighted a possible link between COVID-19 vaccination or infection and Herpesviridae co-infection or reactivation. The authors ...

You can have herpes for years without symptoms, but it can still be spread to others. The herpes virus stays in the body for life and can become active at any time. It's entirely possible to carry the ...

The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...